Management of Recurrent Meningioma

Meningiomas are the most common non-malignant benign (non-cancerous) brain tumors in the US. Though they are considered benign, these tumors can pose challenges for patients, especially when they recur. Join this webinar to learn more about recurrent meningiomas and their management. Presented by: Gelareh Zadeh, MD, PhD, FRCS(C), FAANS Dan Family Chair and Professor of Neurosurgery University of Toronto Webinar Overview: • Learn about the incidence of recurrence in meningiomas • Identify standard and novel treatment strategies for recurrent meningioma • Discuss the long-term effects of recurrent meningioma on the quality of life • Understand how to manage symptoms and side effects related to this diagnosis ~Video Contents~ 00:00 Introduction 02:42 Incidence and Recurrence in Meningioma 14:18 Meningioma Grades - WHO 2021 Grading 22:10 Managing Recurrent Meningioma - Treatments & Side Effects 32:18 Advancements in Diagnosis and Predictors of Recurrence in Meningioma 40:53 Clinical Trials 44:47 Symptom Management and Quality of Life 48:51 Q&A For more information, resources or support, visit the abta.org, call (800) 886-2282 or email [email protected].